A few have moved toward prescribing liraglutide, a related but less effective drug that remains eligible for compounding
[DOI] [PMC free article] [PubMed] [Google Scholar] 63.Qi X., Yun C., Sun L., Xia J., Wu Q., Wang Y., Wang L., Zhang Y., Liang X., Wang L., et al
Key terms include: $150 million upfront payment to Yao Pharma Up to $1.935 billion in development, regulatory, and commercial milestone payments Tiered royalties on future global sales Coverage across all therapeutic, diagnostic, and prophylactic indications for both human and veterinary use This structure positions the agreement as one of the larger oral-GLP-1 licensing deals in recent years
The size of the gummies are small and they have a nice texture
Combating Common Side Effects Some common side effects of GLP-1 therapies include fatigue, nausea, and cognitive fog